Table 3.
Clinicopathological factors and univariate survival analyses
| n | 5-yr survival (%) | P | |
| Age (mean: 68.9) | |||
| ≤ 68 | 31 | 45.5 | 0.415 (NS) |
| > 68 | 40 | 26.2 | |
| Gender | |||
| Male | 53 | 31.0 | 0.510 (NS) |
| Female | 18 | 50.1 | |
| Tumor diameter (mm, mean: 84) | |||
| ≤ 84 | 39 | 34.4 | 0.213 (NS) |
| > 84 | 32 | 33.9 | |
| Histological type | |||
| Differentiated | 31 | 18.6 | 0.565 (NS) |
| Undifferentiaed | 40 | 40.7 | |
| Number of lymph node meta | |||
| N0 or N1 | 19 | 67.4 | < 0.05 |
| N2 or N3 | 52 | 23.8 | |
| MLR (mean: 0.27) | |||
| ≤ 0.27 | 46 | 38.9 | 0.083 (NS) |
| > 0.27 | 25 | 20.7 | |
| Lymphatic invasion | |||
| ly0 or ly1 | 17 | 49.3 | 0.453 (NS) |
| ly2 or ly3 | 54 | 29.7 | |
| Venous invasion | |||
| v0 or v1 | 53 | 45.7 | < 0.05 |
| v2 or v3 | 18 | 9.7 | |
| Peritoneal washing cytology | |||
| Negative (CY0) | 44 | 47.6 | < 0.01 |
| Positive (CY1) | 27 | 15.2 |
NS: Not significant.